KRAS and neoplasm: Therefore, one possible explanation could be that tumors with certain molecular features, such as for example a mutation in the KRAS oncogene, produce more micrometastases in the liver, which are preoperatively undetectable by current imaging methods due to their small size but become visible over time with tumor growth and are therefore responsible for rapid tumor “recurrence” after surgery.